View Older Stories View More Recent Stories
-
Acuity Brands (AYI) PT Lowered to $105 at Roth Capital
-
UPDATE: Roth Capital Upgrades Wynn Resorts (WYNN) to Buy
-
Acuity Brands (AYI) PT Lowered to $105 at Roth Capital
-
XpresSpa Group Inc (XSPA) PT Lowered to $2 at Roth Capital
-
Roth Capital Starts New York & Co (NWY) at Buy
-
Roth Capital Starts Allena Pharmaceuticals (ALNA) at Buy, $61 Target, 'Significantly Undervalued'
-
JinkoSolar Holding Co., Ltd. (JKS) PT Lowered to $19 at Roth Capital Following 4Q
-
Shotspotter (SSTI): Muni Contract Wins And Federal Budget Drive PT To $36 - Roth
-
Roth Capital Upgrades Sierra Wireless (SWIR) to Buy Citing Valuation/IoT Opportunities, Says Concerns are Discounted
-
Roth Capital Downgrades NovaBay Pharmaceuticals (NBY) to Neutral
-
Roth Capital Remains Bullish on TPI Composites, Inc. (TPIC) Following Announced Contract Win
-
Auryn Resources Announces Closing of US$9.8 Million Financing
-
SMART Global Holdings (SGH) PT Raised to $70 at Roth Capital Following 2Q
-
iPass Inc. (IPAS) PT Maintained at $2 at Roth Capital; 'WiFi Continues to Grow as Percentage of Traffic'
-
Roth Capital Downgrades Cogentix Medical (CGNT) to Neutral Following Acquisition
-
Gaiam (GAIA) Prices 2.33M Offering of Class A Common Stock at $15/Share
-
Gaia Announces Pricing of Public Offering of Class A Common Stock
-
AIT Therapeutics (AITB) PT Lowered to $13 at Roth Capital; '4Q17 Recap - PPHN the Focus'
-
Trump Tariffs Present Overhang for Chinese Solar Names - Roth
-
GlycoMimetics (GLYC) Prices 7M Share Common Offering at $17/Sh
-
GlycoMimetics Announces Pricing of Public Offering of Common Stock
-
Restoration Robotics (HAIR) PT Raised to $11 at Roth Capital Citing Expectations for Multiple Expansion
-
UPDATE: Catalyst Pharmaceutical Partners (CPRX) PT Raised to $6 at Roth Capital Following 4Q
-
Fitbit (FIT) Versa and Ace Diversify the Base-Roth
-
Canadian Solar (CSIQ): Inline Q4, Asset Value Provides Upside - Roth
-
Ritter Pharmaceuticals (RTTR) PT Lowered to $1.75 at Roth Capital
-
Roth Capital Downgrades Klondex Mines (KLDX) to Neutral Following Acquisition
-
Roth Capital Reiterates Buy on Madrigal Pharma (MDGL) Following 4Q and Clinical Confusion
-
UPDATE: Clarus Corp (CLAR) PT Lowered to $7 at Roth Capital
-
American Vanguard Corp. (AVD) PT Lowered to $26 at Roth Capital
-
Iconix Brand (ICON) PT Lowered to $1.50 at Roth Capital
-
Mindbody (MB) PT Raised to $46 at Roth Capital
-
UPDATE: Roth Capital Downgrades Himax Technologies (HIMX) to Neutral
-
Roth Capital Reiterates Buy on Green Plains (GPRE); Sees EVP Waiver Comming Shortly
-
Semtech Corp. (SMTC) PT Raised to $45 at Roth Capital; 'Data Center and LoRa Remain Drivers'
-
BG Staffing (BGSF) PT Raised to $21 at Roth Capital; 'Anticipation of Strong EPS Growth in 2018'
-
NantKwest to Present at Upcoming Investment and Healthcare Conferences
-
GT Biopharma to Present at Roth Capital Partners 30th Annual Conference
-
W&T Offshore to Participate in the ROTH Capital Partners 30th Annual Growth Stock Conference
-
Level Brands, Inc. to Participate in Brand Panel Discussion at ROTH Capital Partners 30th Annual Growth Stock Conference on March 12, 2018
-
SinglePoint Video Series Episode 3: SinglePoint Management Recaps Key Initiatives
-
Blast Closes $5M Seed to Turn Games Into Micro-Savings Tools
-
Roth Capital Remains Bullish on FuelCell Energy (FCEL) Following 1Q
-
Delcath to Present at 30th Annual Roth Conference
-
Polar Power (POLA) PT Lowered to $4.50 at Roth Capital
-
Roth Capital Upgrades Pointer Telocation (PNTR) to Buy
-
InMed to Present at 30th Annual ROTH Capital Conference
-
PCM, Inc. Announces Participation in the 30th Annual Roth Capital Conference
-
Q BioMed Inc. to Present at 30th Annual Roth Conference, Taking Place March 11-14, 2018, in Dana Point, CA
-
The Hackett Group to Present at the 30th Annual ROTH Capital Partners Conference on Monday, March 12, 2018

